OnTheIssuesLogo

Lou Barletta on Drugs

 

 


Exempt industrial hemp from marijuana laws.

Barletta co-sponsored Industrial Hemp Farming Act

Congressional Summary:Amends the Controlled Substances Act to exclude industrial hemp from the definition of "marihuana." Defines "industrial hemp" to mean the plant Cannabis sativa and any part of such plant, whether growing or not, with a THC concentration of not more than 0.3%.

Argument in favor (Sen. Ron Wyden):

Members of Congress hear a lot about how dumb regulations are hurting economic growth and job creation. The current ban on growing industrial hemp is hurting job creation in rural America and increasing our trade deficit. This bill will end this ridiculous regulation. Right now, the US is importing over $10 million in hemp products--a crop that US farmers could be profitably growing right here at home, if not for government rules prohibiting it. Now, even though hemp and marijuana come from the same species of plant, there are major differences between them. The Chihuahua and St. Bernard come from the same species, too, but no one is going to confuse them.

Argument in opposition (Drug Enforcement Agency):

Argument in opposition (DrugWatch.org 10/30/2013):

Source: S.359/H.R.525 14_H0525 on Feb 14, 2013

Rated C- by NORML, indicating a "hard-on-drugs" stance.

Barletta scores C- by the NORML on drug reform

OnTheIssues.org interprets the 2016 NORML scores as follows:

About NORML (from their website, www.norml.org):

National Organization for the Reform of Marijuana Law's mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty.

NORML is a nonprofit, public-interest lobby that for more than 30 years has provided a voice for those Americans who oppose marijuana prohibition. We represent the interests of the tens of millions of Americans who smoke marijuana responsibly and believe the recreational and medicinal use of marijuana should no longer be a crime.

NORML supports the removal of all criminal penalties for the private possession & responsible use of marijuana by adults, including the cultivation for personal use, and the casual nonprofit transfers of small amounts. This model is called "decriminalization."

NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as "legalization."

NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.

NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.

Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.

Source: NORML website 16_NORML on Nov 8, 2016

Other candidates on Drugs: Lou Barletta on other issues:
PA Gubernatorial:
Allyson Schwartz
John Fetterman
Ken Krawchuk
Mark Critz
Michael Nutter
Scott Wagner
Tom Corbett
Tom Wolf
PA Senatorial:
Bob Casey
Everett Stern
Jim Christiana
Joe Sestak
John Fetterman
Katie McGinty
Pat Toomey
Rick Saccone

PA politicians
PA Archives
Senate races 2019-20:
AK: Sullivan(R,incumbent) vs.Gross(I)
AL: Jones(D,incumbent) vs.Sessions(R) vs.Moore(R) vs.Mooney(R) vs.Rogers(D) vs.Tuberville(R) vs.Byrne(R) vs.Merrill(R)
AR: Cotton(R,incumbent) vs.Mahony(D) vs.Whitfield(I) vs.Harrington(L)
AZ: McSally(R,incumbent) vs.Kelly(D)
CO: Gardner(R,incumbent) vs.Hickenlooper(D) vs.Madden(D) vs.Baer(D) vs.Walsh(D) vs.Johnston(D) vs.Romanoff(D) vs.Burnes(D) vs.Williams(D)
DE: Coons(D,incumbent) vs.Scarane(D)
GA-2: Isakson(R,resigned) Loeffler(R,appointed) vs.Lieberman(D) vs.Collins(R) vs.Carter(D)
GA-6: Perdue(R,incumbent) vs.Tomlinson(D) vs.Ossoff(D) vs.Terry(D)
IA: Ernst(R,incumbent) vs.Graham(D) vs.Mauro(D) vs.Greenfield(D)
ID: Risch(R,incumbent) vs.Harris(D) vs.Jordan(D)
IL: Durbin(D,incumbent) vs.Curran(R) vs.Stava-Murray(D)
KS: Roberts(R,retiring) vs.LaTurner(R) vs.Wagle(R) vs.Kobach(R) vs.Bollier(D) vs.Lindstrom(R) vs.Grissom(D) vs.Marshall(R)
KY: McConnell(R,incumbent) vs.McGrath(D) vs.Morgan(R) vs.Cox(D) vs.Tobin(D)
LA: Cassidy(R,incumbent) vs.Pierce(D)

MA: Markey(D,incumbent) vs.Liss-Riordan(D) vs.Ayyadurai(R) vs.Kennedy(D)
ME: Collins(R,incumbent) vs.Sweet(D) vs.Gideon(D) vs.Rice(D)
MI: Peters(D,incumbent) vs.James(R)
MN: Smith(D,incumbent) vs.Carlson(D) vs.Lewis(R) vs.Overby(g)
MS: Hyde-Smith(R,incumbent) vs.Espy(D) vs.Bohren(D)
MT: Daines(R,incumbent) vs.Collins(D) vs.Bullock(D)
NC: Tillis(R,incumbent) vs.E.Smith(D) vs.S.Smith(R) vs.Cunningham(D) vs.Tucker(R) vs.Mansfield(D)
NE: Sasse(R,incumbent) vs.Janicek(R)
NH: Shaheen(D,incumbent) vs.Martin(D) vs.Bolduc(R) vs.O'Brien(f)
NJ: Booker(D,incumbent) vs.Singh(R) vs.Meissner(R)
NM: Udall(D,retiring) vs.Clarkson(R) vs.Oliver(D) vs.Lujan(D) vs.Rich(R)
OK: Inhofe(R,incumbent) vs.Workman(D)
OR: Merkley(D,incumbent) vs.Romero(R)
RI: Reed(D,incumbent) vs.Waters(R)
SC: Graham(R,incumbent) vs.Tinubu(D) vs.Harrison(D)
SD: Rounds(R,incumbent) vs.Borglum(R) vs.Ahlers(D)
TN: Alexander(R,incumbent) vs.Sethi(R) vs.Mackler(D) vs.Hagerty(R)
TX: Cornyn(R,incumbent) vs.Hegar(D) vs.Hernandez(D) vs.Bell(D) vs.Ramirez(D) vs.West(D)
VA: Warner(D,incumbent) vs.Taylor(R) vs.Gade(R)
WV: Capito(R,incumbent) vs.Swearengin(D) vs.Ojeda(D)
WY: Enzi(R,incumbent) vs.Ludwig(D) vs.Lummis(R)
Abortion
Budget/Economy
Civil Rights
Corporations
Crime
Drugs
Education
Energy/Oil
Environment
Families
Foreign Policy
Free Trade
Govt. Reform
Gun Control
Health Care
Homeland Security
Immigration
Jobs
Principles
Social Security
Tax Reform
Technology
War/Peace
Welfare

Other Senators
Senate Votes (analysis)
Bill Sponsorships
Affiliations
Policy Reports
Group Ratings

Contact info:
House Contact
Mailing Address:
Office 510 CHOB, Wash., DC 20515
Phone number:
202-225-6511





Page last updated: Mar 26, 2020